Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

NCT00414193 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00414193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00414193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
February 28, 2007
Completion date
December 31, 2017
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ampc beta-lactamase, bacteremia